about
Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis CLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Virological Mechanisms in the Coinfection between HIV and HCVEpidemiology of hepatitis C in Croatia in the European contextHepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexusClinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis CEnhancing our understanding of current therapies for hepatitis C virus (HCV)HIV, Aging, and Viral Coinfections: Taking the Long View.Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patientsCD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.Molecular mechanisms of liver fibrosis in HIV/HCV coinfectionHIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells.A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.Human immunodeficiency virus and liver disease: An update.SIV-induced Translocation of Bacterial Products in the Liver Mobilizes Myeloid Dendritic and Natural Killer Cells Associated With Liver DamageCombination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis.HIV infection and immune activation: the role of coinfections.Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus CoinfectionIsolated Hepatitis B Core Antibody Status Is Not Associated With Accelerated Liver Disease Progression in HIV/Hepatitis C CoinfectionReduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver diseasePharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIVMechanisms of Accelerated Liver Fibrosis Progression during HIV Infection.Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.Direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection: Interferon free is now.Clinical and Pathological Risk Factors Associated with Liver Fibrosis and Steatosis in African-Americans with Chronic Hepatitis C.Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients.Analysis of Non-AIDS-Defining Events in HIV Controllers.Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.Aspartate transaminase-platelet ratio and Fibrosis-4 indices as effective markers for monitoring esophageal varices in HIV/hepatitis C virus co-infected patients due to contaminated blood products for hemophilia.Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics.Innate and Adaptive Immune Responses in Chronic HCV Infection.Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.
P2860
Q26741123-2214D212-ADA4-4678-A659-CB66D8941747Q26777511-4D0CD4A5-1FEF-4289-B326-16A55358FE4FQ26780313-A6F8753F-1792-4689-81BC-7F92FCCAA006Q26795602-68C5F64A-B73C-4EA5-AB0C-1A10C0D50856Q26798469-CCE0B462-38B6-4373-ADCF-3B52394195AFQ26991958-15A4EE4C-D809-4545-8055-B3E81B942755Q28080225-B833EB97-EF1F-4FB7-AC85-4C0B0A7D703FQ28085718-9A237D82-DE54-4B68-8ADF-010F4D7E345BQ30245486-86A51962-7B18-4A4B-8C10-D87775E10879Q33638134-265C57F6-1031-4131-B0DF-279D9542C931Q33787675-4EE1AF1D-1B99-4E1A-A927-7A8437327EF9Q33874737-070D55A8-82A7-42D5-AF77-864392F1C0ABQ33907429-CCCAFF9C-F9F4-4918-9B39-5E95E4BBC937Q36065064-03F0A50E-B1A5-4D37-9CE1-F3CDA0568D6FQ36084923-0D85FF22-9C15-4A55-8D6E-4CBD2CC4A8DBQ36378109-28187CDF-066E-42A1-A71B-95C96801020FQ36440241-9173B7DC-36FC-495C-884A-10B07ED934DDQ36566930-D81210ED-0C01-4D97-BB41-1759A627938EQ36628383-4F759796-3ADA-495E-A7C7-A8BB99EEDBFCQ36754790-B01BBC67-8CC6-4712-B4E9-28D3381A2A6BQ36796783-D895B931-ED95-4856-AEBC-E43BDBE0681BQ37003049-44D09A62-2945-4D20-B9B3-4D3DC36FE383Q37014002-5AF4BDA0-7E45-48D1-90CD-73001B156521Q37046208-9B27A893-7059-4F7A-93DC-75BB12956637Q37055231-039253E0-9F40-4446-8F14-92FEACE693A9Q37578291-17945785-AE8E-43C9-8979-0FC57DBAE3C1Q37642114-19540259-F614-418A-95B2-F412182DC873Q38515906-640F337A-9954-4E89-B150-25B053125F09Q38544578-A0337350-54E5-4F7E-98CB-D423DB649CDDQ38548066-59A5501B-0E0B-4D47-84D0-DB66CFDD9D3EQ38726664-38D0C196-382F-4366-AFF1-AA75B215CA02Q38751493-AF973C69-1632-40E0-B8A1-1811DB7085DFQ38900456-59DCBDC1-C13E-4CA4-AF3B-4522E1E2CBA2Q38946641-C65F4598-A240-45D2-8B0A-282BA1AD834CQ39952253-42DF8E99-D963-4521-962B-238DE0FE0793Q40334457-9C41DADD-4ABA-4823-BE12-3F746CCF2D6FQ40355161-F25649D9-7A40-4BF4-87CE-9759A27C1CE0Q40394363-A58B7E27-8932-4C24-85D2-34C389C91039Q41035955-ACD7C483-AA82-4D13-84C4-50F7F52B66F6Q41920886-4DCAF428-D392-4F84-B2A3-9D246039ECBC
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HCV and HIV co-infection: mechanisms and management.
@ast
HCV and HIV co-infection: mechanisms and management.
@en
type
label
HCV and HIV co-infection: mechanisms and management.
@ast
HCV and HIV co-infection: mechanisms and management.
@en
prefLabel
HCV and HIV co-infection: mechanisms and management.
@ast
HCV and HIV co-infection: mechanisms and management.
@en
P2860
P356
P1476
HCV and HIV co-infection: mechanisms and management
@en
P2093
Jennifer Y Chen
Raymond T Chung
P2860
P2888
P304
P356
10.1038/NRGASTRO.2014.17
P407
P577
2014-02-18T00:00:00Z